Trying to separate three different claims about melanotan II: that it is the right molecule, that it is the right dose, and that it does something useful.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Willing to accept that my own experience is the weakest evidence in the room.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing. Same for me with melanotan II, unfortunately.
Narrow conclusion.